Branch Therapeutics

Developing orally bioavailable, multi-targeted cancer therapies to address key oncogenic drivers with improved safety and efficacy.

HQ location

Tucson, United States

Launch date

Nov 2024

Enterprise value

$16—24m

loading funding rounds…

Unlock the full power of analytics with a premium account

Track company size and historic growth

Track team composition and strength

Track website visits and app downloads